Managing Insulin Resistance Before Pregnancy May Improve Fertility and Birth Outcomes for Women with PCOS

Recent research indicates that elevated prepregnancy insulin resistance is significantly associated with lower fertility rates and increased obstetric complications, including preeclampsia, in women with polycystic ovary syndrome (PCOS). A secondary analysis of the PPCOS II clinical trial, published in Obstetrics & Gynecology, suggests that addressing metabolic health through lifestyle modifications and medications before conception may improve reproductive success and lower the risk of dangerous pregnancy-related conditions.

How Insulin Resistance Impacts Fertility

Insulin resistance—a condition where the body’s cells do not respond effectively to insulin—is a hallmark of PCOS. According to data from 746 women analyzed in the study, those with higher insulin resistance levels, measured by the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), faced significant reproductive hurdles. Women in the highest quartile of insulin resistance experienced lower ovulation rates (73.8% compared to 93.5% in the lowest quartile) and reduced clinical pregnancy rates.

The study found that the duration of infertility was longer for those with higher insulin resistance, with a median of 36 months compared to 18.5 to 24 months for those with lower levels. Researchers observed that as insulin resistance severity increased, live birth rates dropped progressively, falling from 35.5% in the first quartile to 18.2% in the fourth quartile.

Reducing Pregnancy Risks Through Metabolic Optimization

The research highlights a critical window for intervention: the prepregnancy period. Improving insulin sensitivity before conception demonstrated a measurable protective effect against obstetric complications. Specifically, improvements in HOMA-IR scores during infertility treatment were linked to a 78% reduced risk of preeclampsia. Furthermore, these improvements were associated with nearly a twofold increase in the odds of achieving a clinical pregnancy.

Dr. Veronica Gomez-Lobo, senior study author and director of pediatric and adolescent gynecology at the Eunice Kennedy Shriver National Institute of Child Health and Human Development, noted that these findings support incorporating metabolic optimization into standard prepregnancy care. While clinicians often wait for pregnancy to manage complications, addressing insulin resistance early could mitigate significant morbidity and mortality associated with conditions like preeclampsia and gestational diabetes.

Clinical Tools for Assessment

While the HOMA-IR index is a standard research tool, it is not yet routinely used in most clinical settings. However, Dr. Basma Faris, an ob/gyn at the Icahn School of Medicine at Mount Sinai, emphasizes that clinicians can identify potential insulin resistance by monitoring fasting glucose and insulin levels. Dr. Faris suggests that patients diagnosed with PCOS should have their metabolic health assessed early and monitored periodically throughout their treatment journey.

According to Dr. Faris, the “toolbox” for improving insulin sensitivity includes:

• Nutrition and Lifestyle Changes: Dietary adjustments and consistent physical activity remain primary interventions.
• Exercise: Regular physical activity improves insulin sensitivity in skeletal muscles, offering both short-term and long-term metabolic benefits.
• Pharmacotherapy: Insulin-sensitizing medications, such as metformin, are frequently used to manage the metabolic components of PCOS.

Key Considerations for Patients

The study underscores that insulin resistance is a modifiable risk factor. For women planning a pregnancy, identifying and addressing metabolic dysfunction early may provide the best opportunity for a healthy outcome. Future clinical protocols may increasingly shift toward treating the underlying metabolic drivers of PCOS rather than focusing solely on ovulation induction or fertility treatments.

Frequently Asked Questions

• What is PCOS/PMOS? Polycystic ovary syndrome (PCOS), sometimes referred to as polyendocrine metabolic ovarian syndrome (PMOS), is a common hormonal disorder that frequently involves insulin resistance and ovulatory dysfunction.
• Why does insulin resistance affect pregnancy? High insulin levels can interfere with normal ovulation and increase the systemic inflammation associated with pregnancy complications like gestational diabetes and preeclampsia.
• Can lifestyle changes fix insulin resistance? Yes, consistent exercise and dietary changes are effective ways to improve how the body uses insulin, which may improve both fertility treatment success and overall pregnancy health.